Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kalinsky

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Cancer Investigation|March 11, 2014
Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancerKevin Kalinsky, Katherine D Crew, Susan Refice, et al.
Cancer|January 9, 2020
Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac eventsDawn L Hershman, Melissa K Accordino, Sherry Shen, et al.
Springerplus|August 5, 2015
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapyChi Zhang, Shuang Wang, Hayley P Israel, et al.
NPJ Breast Cancer|July 17, 2025
Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trialYee Hoon Foong, Qi Wang, Matthew Kearney, et al.
The Breast Journal|April 17, 2015
Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In SituLaura L Reimers, Parijatham S Sivasubramanian, Dawn Hershman, et al.
Journal of Cancer Survivorship : Research and Practice|April 22, 2016
Survivorship care plans and adherence to lifestyle recommendations among breast cancer survivorsHeather Greenlee, Christine L Sardo Molmenti, Katherine D Crew, et al.
Breast Cancer Research and Treatment|May 16, 2022
Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancerJulia E McGuinness, Vicky Ro, Simukayi Mutasa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2025
Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2- advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, -3, and -7 trialsLowell L Hart, Seock-Ah Im, Sara M Tolaney, et al.
Radiology|February 13, 2018
Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast CancerJacqueline E Gunther, Emerson A Lim, Hyun K Kim, et al.
JCO Precision Oncology|March 28, 2025
Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorCarolyn K McCourt, Jacob Gross, Kevin Kalinsky, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Cancer Investigation|March 11, 2014
Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancerKevin Kalinsky, Katherine D Crew, Susan Refice, et al.
Cancer|January 9, 2020
Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac eventsDawn L Hershman, Melissa K Accordino, Sherry Shen, et al.
Springerplus|August 5, 2015
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapyChi Zhang, Shuang Wang, Hayley P Israel, et al.
NPJ Breast Cancer|July 17, 2025
Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trialYee Hoon Foong, Qi Wang, Matthew Kearney, et al.
The Breast Journal|April 17, 2015
Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In SituLaura L Reimers, Parijatham S Sivasubramanian, Dawn Hershman, et al.
Journal of Cancer Survivorship : Research and Practice|April 22, 2016
Survivorship care plans and adherence to lifestyle recommendations among breast cancer survivorsHeather Greenlee, Christine L Sardo Molmenti, Katherine D Crew, et al.
Breast Cancer Research and Treatment|May 16, 2022
Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancerJulia E McGuinness, Vicky Ro, Simukayi Mutasa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2025
Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2- advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, -3, and -7 trialsLowell L Hart, Seock-Ah Im, Sara M Tolaney, et al.
Radiology|February 13, 2018
Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast CancerJacqueline E Gunther, Emerson A Lim, Hyun K Kim, et al.
JCO Precision Oncology|March 28, 2025
Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorCarolyn K McCourt, Jacob Gross, Kevin Kalinsky, et al.
Pageof 16